Haemostatic, lipid, and blood-pressure profiles of women on oral contraceptives containing 50 microgram or 30 microgram oestrogen
- PMID: 72289
- DOI: 10.1016/s0140-6736(77)90888-1
Haemostatic, lipid, and blood-pressure profiles of women on oral contraceptives containing 50 microgram or 30 microgram oestrogen
Abstract
In 15 women on oral contraceptives containing 30 microgram oestrogen, mean values for factors II, VII, and X, fibrinogen, fibrinolytic activity, antithrombin III, cholesterol, and fasting triglycerides were intermediate between values for 63 women on preparations containing 50 microgram oestrogen and those for 243 premenopausal women not on oral contraceptives. Mean blood-pressure levels, however, were higher in women on 30 microgram than in those on 50 microgram preparations. In 28 women on 50 microgram preparations containing 3 mg or 4 mg norethisterone, mean values of factor VII, fibrinogen, fibrinolytic activity, cholesterol, fasting triglycerides, and systolic blood-pressure were higher than in 15 women whose preparations contained only 1 mg of norethisterone. A less consistent picture was found in women on 30 microgram oestrogen preparations containing either 250 microgram (10 women) or 150 microgram (5 women) d-norgestrel. It is concluded that 30 microgram oestrogen preparations probably result in smaller hemostatic and lipid changes than 50 microgram preparations but that they may have a blood-pressure-raising effect attributable to the particular progestagen, d-norgestrel, used in 30 microgram preparations. The safety of these 30 microgram oestrogen preparations may thus depend partly on the balance between these two sets of effects. It is also concluded that norethisterone may have effects similar to those attributed to oestrogens.
Similar articles
-
An epidemiological study of the haemostatic and other effects of oral contraceptives.Br J Haematol. 1976 Nov;34(3):353-64. doi: 10.1111/j.1365-2141.1976.tb03582.x. Br J Haematol. 1976. PMID: 990177
-
Metabolic effects of oral contraceptives containing 30 micrograms and 50 micrograms of oestrogen.Med J Aust. 1979 Sep 22;2(6):277-81. Med J Aust. 1979. PMID: 230411
-
Comparative study of the effects of two once-a-month injectable contraceptives (Cyclofem and Mesigyna) and one oral contraceptive (Ortho-Novum 1/35) on coagulation and fibrinolysis.Contraception. 2003 Sep;68(3):159-76. doi: 10.1016/s0010-7824(03)00164-1. Contraception. 2003. PMID: 14561536 Clinical Trial.
-
A randomized prospective study of the metabolic effects of four low-estrogen oral contraceptives.J Reprod Med. 1983 Jan;28(1 Suppl):92-9. J Reprod Med. 1983. PMID: 6403706 Clinical Trial.
-
Metabolic side-effects of oral contraceptives.Clin Endocrinol Metab. 1973 Nov;2(3):503-25. doi: 10.1016/s0300-595x(73)80012-x. Clin Endocrinol Metab. 1973. PMID: 4591141 Review. No abstract available.
Cited by
-
Estrogen modulates ClC-2 chloride channel gene expression in rat kidney.Pflugers Arch. 2003 Aug;446(5):593-9. doi: 10.1007/s00424-003-1095-y. Epub 2003 Jun 17. Pflugers Arch. 2003. PMID: 12811561
-
Successful pregnancy soon after oral contraceptive-associated malignant hypertension.Postgrad Med J. 1980 Nov;56(661):790-1. doi: 10.1136/pgmj.56.661.790. Postgrad Med J. 1980. PMID: 7267484 Free PMC article.
-
Hypertension Across a Woman's Life Cycle.Curr Hypertens Rep. 2022 Dec;24(12):723-733. doi: 10.1007/s11906-022-01230-4. Epub 2022 Nov 9. Curr Hypertens Rep. 2022. PMID: 36350493 Free PMC article. Review.
-
Blood pressure and contraceptive use.Br Med J (Clin Res Ed). 1982 Aug 7;285(6339):403-7. doi: 10.1136/bmj.285.6339.403. Br Med J (Clin Res Ed). 1982. PMID: 6809102 Free PMC article.
-
The effect of low-dose estroprogestinic preparations on prothrombin complex factors: no significant increase after an 8-month trial.Blut. 1985 Mar;50(3):141-8. doi: 10.1007/BF00320070. Blut. 1985. PMID: 3978241
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources